Madrigal Pharmaceuticals Ownership 2024 | Who Owns Madrigal Pharmaceuticals Now?


OverviewForecastFinancialsChartTranscripts

Institutional Ownership

32.90%

Insider Ownership

15.35%

Retail Ownership

51.75%

Institutional Holders

155.00

Madrigal Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JANUS HENDERSON GROUP PLC13.16%0.38%2,601,282-300,768-10.36%694,526,099Mar 31, 2024
BAKER BROS. ADVISORS LP9.97%6.60%1,969,798--526,014,858Mar 31, 2024
AVORO CAPITAL ADVISORS LLC9.84%6.06%1,944,44455,5562.94%519,244,326Mar 31, 2024
PAULSON & CO. INC.8.98%32.74%1,775,000669,25960.53%473,996,000Mar 31, 2024
VANGUARD GROUP INC8.45%0.01%1,668,80694,0645.97%445,637,954Mar 31, 2024
BLACKROCK INC.6.13%0.01%1,210,391-2,171-0.18%323,222,813Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/4.06%0.03%803,213414,484106.63%214,491,000Mar 31, 2024
FMR LLC3.61%0.01%713,91488,74914.20%190,643,595Mar 31, 2024
STATE STREET CORP3.16%0.01%624,938-75,801-10.82%166,883,444Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP2.18%0.02%430,500430,500100.00%114,960,720Mar 31, 2024
PERCEPTIVE ADVISORS LLC2.18%1.99%429,953278,802184.45%114,814,649Mar 31, 2024
ARTISAN PARTNERS LIMITED PARTNERSHIP2.03%0.16%401,709105,22935.49%107,272,371Mar 31, 2024
RTW INVESTMENTS, LP2.01%1.57%397,047-418,144-51.29%106,027,431Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC1.76%0.01%346,85710,6023.15%92,638,421Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.69%0.02%333,800333,800100.00%89,137,952Mar 31, 2024
MORGAN STANLEY1.46%0.01%288,606136,68889.97%77,069,442Mar 31, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP1.45%1.94%285,93187,76244.29%76,355,014Mar 31, 2024
RA CAPITAL MANAGEMENT, L.P.1.03%0.08%204,500--54,609,680Mar 31, 2024
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC1.00%4.23%196,995-127,624-39.31%52,605,545Mar 31, 2024
PICTET ASSET MANAGEMENT HOLDING SA0.93%0.05%184,16312,9987.59%48,426,921Mar 31, 2024

Madrigal Pharmaceuticals's largest institutional shareholder is JANUS HENDERSON GROUP PLC, holding 13.16% of the company's total share outstanding, currently valued at $694.53M. The top 10 institutional shareholders own together 69.54% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
TAO CAPITAL MANAGEMENT LP0.66%33.02%130,529--34,856,464Mar 31, 2024
PAULSON & CO. INC.8.98%32.74%1,775,000669,25960.53%473,996,000Mar 31, 2024
UNIVERSITY OF WISCONSIN FOUNDATION0.29%16.99%56,376-17,111-23.28%15,054,647Mar 31, 2024
ALPINVEST PARTNERS B.V.0.54%11.03%105,744-105,744-50.00%28,237,878Mar 31, 2024
PROPEL BIO MANAGEMENT, LLC0.22%6.69%43,03213,00043.29%11,491,265Mar 31, 2024
BAKER BROS. ADVISORS LP9.97%6.60%1,969,798--526,014,858Mar 31, 2024
AVORO CAPITAL ADVISORS LLC9.84%6.06%1,944,44455,5562.94%519,244,326Mar 31, 2024
TRI LOCUM PARTNERS LP0.27%4.94%53,35527,831109.04%14,247,919Mar 31, 2024
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC1.00%4.23%196,995-127,624-39.31%52,605,545Mar 31, 2024
SIO CAPITAL MANAGEMENT, LLC0.26%4.06%51,00051,000100.00%13,619,040Mar 31, 2024
AFFINITY ASSET ADVISORS, LLC0.58%3.80%115,00015,00015.00%30,709,600Mar 31, 2024
683 CAPITAL MANAGEMENT, LLC0.90%3.48%177,900167,9001679.00%47,506,416Mar 31, 2024
TCG CROSSOVER MANAGEMENT, LLC0.76%3.15%149,283-30,634-17.03%39,864,532Mar 31, 2024
BIOIMPACT CAPITAL LLC0.31%2.64%61,39920,48950.08%16,395,989Mar 31, 2024
PERCEPTIVE ADVISORS LLC2.18%1.99%429,953278,802184.45%114,814,649Mar 31, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP1.45%1.94%285,93187,76244.29%76,355,014Mar 31, 2024
EXOME ASSET MANAGEMENT LLC0.04%1.81%7,900-5,302-40.16%2,109,616Mar 31, 2024
RTW INVESTMENTS, LP2.01%1.57%397,047-418,144-51.29%106,027,431Mar 31, 2024
IKARIAN CAPITAL, LLC0.26%1.50%51,40051,400100.00%13,725,856Mar 31, 2024
RHEOS CAPITAL WORKS INC.0.56%1.41%110,215110,215100.00%29,432,000Mar 31, 2024

The largest Madrigal Pharmaceuticals shareholder by % of total assets is TAO CAPITAL MANAGEMENT LP. The company owns 130.53K shares of Madrigal Pharmaceuticals (MDGL), representing 33.02% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PAULSON & CO. INC.8.98%32.74%1,775,000669,25960.53%473,996,000Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP2.18%0.02%430,500430,500100.00%114,960,720Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/4.06%0.03%803,213414,484106.63%214,491,000Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.69%0.02%333,800333,800100.00%89,137,952Mar 31, 2024
PERCEPTIVE ADVISORS LLC2.18%1.99%429,953278,802184.45%114,814,649Mar 31, 2024
683 CAPITAL MANAGEMENT, LLC0.90%3.48%177,900167,9001679.00%47,506,416Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.0.76%0.10%150,000150,000100.00%40,056,000Mar 31, 2024
MORGAN STANLEY1.46%0.01%288,606136,68889.97%77,069,442Mar 31, 2024
POLAR CAPITAL HOLDINGS PLC0.63%0.18%125,205125,205100.00%33,434,743Mar 31, 2024
TWIN TREE MANAGEMENT, LP0.62%0.07%122,200122,200100.00%32,632,289Mar 31, 2024
ARMISTICE CAPITAL, LLC0.85%0.59%168,000118,000236.00%44,862,720Mar 31, 2024
ARTAL GROUP S.A.0.56%0.75%110,507110,507100.00%29,509,789Mar 31, 2024
RHEOS CAPITAL WORKS INC.0.56%1.41%110,215110,215100.00%29,432,000Mar 31, 2024
ARTISAN PARTNERS LIMITED PARTNERSHIP2.03%0.16%401,709105,22935.49%107,272,371Mar 31, 2024
LORD, ABBETT & CO. LLC0.49%0.09%97,10397,103100.00%25,931,000Mar 31, 2024
VANGUARD GROUP INC8.45%0.01%1,668,80694,0645.97%445,637,954Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.0.47%0.06%93,57193,571100.00%24,987,200Mar 31, 2024
FMR LLC3.61%0.01%713,91488,74914.20%190,643,595Mar 31, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP1.45%1.94%285,93187,76244.29%76,355,014Mar 31, 2024
ECOR1 CAPITAL, LLC0.38%0.51%75,00075,000100.00%20,028,000Mar 31, 2024

As of Mar 31 2024, Madrigal Pharmaceuticals's largest institutional buyer is PAULSON & CO. INC.. The company purchased 669.26K stocks of MDGL, valued at $474.00M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RTW INVESTMENTS, LP2.01%1.57%397,047-418,144-51.29%106,027,431Mar 31, 2024
ALLIANCEBERNSTEIN L.P.0.14%0.00%27,900-311,854-91.79%7,450,416Mar 31, 2024
JANUS HENDERSON GROUP PLC13.16%0.38%2,601,282-300,768-10.36%694,526,099Mar 31, 2024
ARMISTICE CAPITAL, LLC----280,000-100.00%-Mar 31, 2024
JANE STREET GROUP, LLC0.13%0.00%25,151-191,667-88.40%6,716,323Mar 31, 2024
GROUP ONE TRADING, L.P.0.22%0.04%43,171-148,760-77.51%11,528,384Mar 31, 2024
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC1.00%4.23%196,995-127,624-39.31%52,605,545Mar 31, 2024
ALPINVEST PARTNERS B.V.0.54%11.03%105,744-105,744-50.00%28,237,878Mar 31, 2024
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC----82,287-100.00%-Mar 31, 2024
STATE STREET CORP3.16%0.01%624,938-75,801-10.82%166,883,444Mar 31, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.----69,406-100.00%-Mar 31, 2024
L1 CAPITAL PTY LTD----50,230-100.00%-Mar 31, 2024
WELLS FARGO & COMPANY/MN0.09%0.00%16,811-42,974-71.88%4,489,137,000Mar 31, 2024
MARSHALL WACE, LLP----33,071-100.00%-Mar 31, 2024
TCG CROSSOVER MANAGEMENT, LLC0.76%3.15%149,283-30,634-17.03%39,864,532Mar 31, 2024
LMR PARTNERS LLP0.11%0.06%22,108-29,777-57.39%5,903,720Mar 31, 2024
SPHERA FUNDS MANAGEMENT LTD.----27,767-100.00%-Mar 31, 2024
ROSALIND ADVISORS, INC.----25,000-100.00%-Mar 31, 2024
STEMPOINT CAPITAL LP----20,444-100.00%-Mar 31, 2024
CUTLER GROUP LLC / CA0.19%0.36%36,900-19,300-34.34%1,092,000Mar 31, 2024

As of Mar 31 2024, Madrigal Pharmaceuticals's biggest institutional seller is RTW INVESTMENTS, LP. The company sold -0.42M shares of MDGL, valued at $106.03M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SUSQUEHANNA INTERNATIONAL GROUP, LLP2.18%0.02%430,500430,500100.00%114,960,720Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.69%0.02%333,800333,800100.00%89,137,952Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.0.76%0.10%150,000150,000100.00%40,056,000Mar 31, 2024
POLAR CAPITAL HOLDINGS PLC0.63%0.18%125,205125,205100.00%33,434,743Mar 31, 2024
TWIN TREE MANAGEMENT, LP0.62%0.07%122,200122,200100.00%32,632,289Mar 31, 2024
ARTAL GROUP S.A.0.56%0.75%110,507110,507100.00%29,509,789Mar 31, 2024
RHEOS CAPITAL WORKS INC.0.56%1.41%110,215110,215100.00%29,432,000Mar 31, 2024
LORD, ABBETT & CO. LLC0.49%0.09%97,10397,103100.00%25,931,000Mar 31, 2024
ECOR1 CAPITAL, LLC0.38%0.51%75,00075,000100.00%20,028,000Mar 31, 2024
IKARIAN CAPITAL, LLC0.26%1.50%51,40051,400100.00%13,725,856Mar 31, 2024
SIO CAPITAL MANAGEMENT, LLC0.26%4.06%51,00051,000100.00%13,619,040Mar 31, 2024
DRIEHAUS CAPITAL MANAGEMENT LLC0.26%0.13%50,70950,709100.00%13,541,331Mar 31, 2024
TWIN TREE MANAGEMENT, LP0.22%0.03%43,80043,800100.00%11,696,352Mar 31, 2024
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.0.22%0.01%42,98642,986100.00%11,479,000Mar 31, 2024
GILDER GAGNON HOWE & CO LLC0.20%0.13%39,08339,083100.00%10,436,724Mar 31, 2024
ROKOS CAPITAL MANAGEMENT LLP0.19%0.05%37,76237,762100.00%10,063,951Mar 31, 2024
ARROWMARK COLORADO HOLDINGS LLC0.17%0.10%34,21934,219100.00%9,137,842Mar 31, 2024
TWIN TREE MANAGEMENT, LP0.15%0.02%30,29730,297100.00%8,090,511Mar 31, 2024
CIBC PRIVATE WEALTH GROUP, LLC0.15%0.02%30,05030,050100.00%7,684,987,000Mar 31, 2024
PFM HEALTH SCIENCES, LP0.15%0.38%29,97329,973100.00%8,003,990Mar 31, 2024
GHISALLO CAPITAL MANAGEMENT LLC0.13%0.76%25,00025,000100.00%6,676,000Mar 31, 2024
WOODLINE PARTNERS LP0.10%0.05%19,70019,700100.00%5,260,688Mar 31, 2024
SOFINNOVA INVESTMENTS, INC.0.10%0.28%19,02919,029100.00%5,081,504Mar 31, 2024
SQUAREPOINT OPS LLC0.08%0.01%15,00015,000100.00%4,005,600Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC0.07%0.08%14,80014,800100.00%3,952,192Mar 31, 2024
BLUE OWL CAPITAL HOLDINGS LP0.07%0.71%13,31913,319100.00%3,556,706Mar 31, 2024
NEWBRIDGE FINANCIAL SERVICES GROUP, INC.0.06%1.29%11,03311,033100.00%2,946,252Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.05%0.00%10,56010,560100.00%2,819,942Mar 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.0.05%0.01%10,00010,000100.00%2,670,400Mar 31, 2024
CASTLEARK MANAGEMENT LLC0.05%0.10%9,2109,210100.00%2,459,438Mar 31, 2024
D. E. SHAW & CO., INC.0.05%0.00%9,1009,100100.00%2,430,064Mar 31, 2024
BARCLAYS PLC0.05%0.00%9,0009,000100.00%2,403,000Mar 31, 2024
PENTWATER CAPITAL MANAGEMENT LP0.02%0.01%4,0004,000100.00%1,068,160Mar 31, 2024
CALAMOS ADVISORS LLC0.02%0.00%3,6133,613100.00%964,816Mar 31, 2024
SHEAFF BROCK INVESTMENT ADVISORS, LLC0.02%0.06%3,6003,600100.00%961,344Mar 31, 2024
TUDOR INVESTMENT CORP ET AL0.01%0.00%2,2002,200100.00%587,488Mar 31, 2024
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC0.01%0.03%2,1862,186100.00%583,749Mar 31, 2024
FNY INVESTMENT ADVISERS, LLC0.01%0.33%2,0752,075100.00%554,000Mar 31, 2024
SOROS FUND MANAGEMENT LLC0.01%0.01%2,0162,016100.00%538,353Mar 31, 2024
OMERS ADMINISTRATION CORP0.01%0.01%1,8001,800100.00%480,672Mar 31, 2024
PARKWOOD LLC0.01%0.04%1,7821,782100.00%476,000Mar 31, 2024
ARTIA GLOBAL PARTNERS LP0.01%0.08%1,5571,557100.00%415,781Mar 31, 2024
ALLIANZ ASSET MANAGEMENT GMBH0.01%0.00%1,5021,502100.00%401,094Mar 31, 2024
LMR PARTNERS LLP0.01%0.00%1,5001,500100.00%400,560Mar 31, 2024
CONCENTRIC CAPITAL STRATEGIES, LP0.01%0.02%1,4991,499100.00%400,293Mar 31, 2024
FRANKLIN RESOURCES INC0.01%0.00%1,4141,414100.00%377,594Mar 31, 2024
OPPENHEIMER & CO INC0.01%0.01%1,2201,220100.00%325,789Mar 31, 2024
TUDOR INVESTMENT CORP ET AL0.01%0.00%1,2001,200100.00%320,448Mar 31, 2024
CONGRESS PARK CAPITAL LLC0.01%0.14%1,2001,200100.00%320,448Mar 31, 2024
CERITY PARTNERS LLC0.01%0.00%1,1421,142100.00%304,960Mar 31, 2024
OVERBROOK MANAGEMENT CORP0.01%0.08%1,1301,130100.00%301,755Mar 31, 2024
WALLEYE CAPITAL LLC0.01%0.00%1,0931,093100.00%291,875Mar 31, 2024
BELLEVUE GROUP AG0.01%0.00%1,0601,060100.00%283,062Mar 31, 2024
CETERA ADVISORS LLC0.01%0.00%1,0511,051100.00%280,659Mar 31, 2024
PITCAIRN CO0.01%0.02%1,0071,007100.00%268,909Mar 31, 2024
PENTWATER CAPITAL MANAGEMENT LP0.01%0.00%1,0001,000100.00%267,040Mar 31, 2024
CENTIVA CAPITAL, LP0.01%0.01%1,0001,000100.00%267,040Mar 31, 2024
SWEET FINANCIAL PARTNERS, LLC0.01%0.06%1,0001,000100.00%267,040Mar 31, 2024
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC0.00%0.00%973973100.00%259,830Mar 31, 2024
COMMONWEALTH EQUITY SERVICES, LLC0.00%0.00%954954100.00%255,000Mar 31, 2024
SASSICAIA CAPITAL ADVISERS LLC0.00%1.02%900900100.00%240,336Mar 31, 2024
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV0.00%0.11%875875100.00%233,660Mar 31, 2024
PFG INVESTMENTS, LLC0.00%0.01%858858100.00%229,120Mar 31, 2024
MACKENZIE FINANCIAL CORP0.00%0.00%799799100.00%213,365Mar 31, 2024
CETERA ADVISOR NETWORKS LLC0.00%0.00%773773100.00%206,422Mar 31, 2024
WALLEYE CAPITAL LLC0.00%0.00%500500100.00%133,520Mar 31, 2024
CREATIVE PLANNING0.00%-400400100.00%3,562Mar 31, 2024
HIGHTOWER ADVISORS, LLC0.00%0.00%300300100.00%41,730Mar 31, 2024
BNP PARIBAS0.00%0.00%255255100.00%68,095Mar 31, 2024
WALLEYE CAPITAL LLC0.00%0.00%200200100.00%53,408Mar 31, 2024
UMB BANK, N.A.0.00%0.00%200200100.00%53,408Mar 31, 2024
CLEAR STREET MARKETS LLC0.00%0.01%200200100.00%53,000Mar 31, 2024
PACER ADVISORS, INC.0.00%0.00%170170100.00%45,397Mar 31, 2024
ENTRYPOINT CAPITAL, LLC0.00%0.04%155155100.00%41,391Mar 31, 2024
ICA GROUP WEALTH MANAGEMENT, LLC0.00%0.00%9090100.00%24,033Mar 31, 2024
COMPAGNIE LOMBARD ODIER SCMA0.00%0.00%8080100.00%21,363Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC0.00%0.00%2929100.00%7,744Mar 31, 2024
FNY INVESTMENT ADVISERS, LLC0.00%0.00%1111100.00%2,000Mar 31, 2024
MEEDER ASSET MANAGEMENT INC0.00%0.00%1010100.00%2,670Mar 31, 2024
ZRC WEALTH MANAGEMENT, LLC-0.00%99100.00%2,404,000Mar 31, 2024
FARMERS & MERCHANTS TRUST CO OF CHAMBERSBURG PA-0.00%88100.00%2,000Mar 31, 2024
QUEST PARTNERS LLC-0.00%44100.00%1,068Mar 31, 2024
WESTEND CAPITAL MANAGEMENT, LLC-0.00%44100.00%1,068Mar 31, 2024
RIGGS ASSET MANAGMENT CO. INC.-0.00%22100.00%535Mar 31, 2024
ATLAS CAPITAL ADVISORS LLC--11100.00%267Mar 31, 2024

Madrigal Pharmaceuticals's largest new institutional shareholder by number of shares is SUSQUEHANNA INTERNATIONAL GROUP, LLP, purchased 430.50K shares, valued at $114.96M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARMISTICE CAPITAL, LLC----280,000-100.00%-Mar 31, 2024
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC----82,287-100.00%-Mar 31, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.----69,406-100.00%-Mar 31, 2024
L1 CAPITAL PTY LTD----50,230-100.00%-Mar 31, 2024
MARSHALL WACE, LLP----33,071-100.00%-Mar 31, 2024
SPHERA FUNDS MANAGEMENT LTD.----27,767-100.00%-Mar 31, 2024
ROSALIND ADVISORS, INC.----25,000-100.00%-Mar 31, 2024
STEMPOINT CAPITAL LP----20,444-100.00%-Mar 31, 2024
OSTERWEIS CAPITAL MANAGEMENT INC----15,147-100.00%-Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC----12,458-100.00%-Mar 31, 2024
MILLENNIUM MANAGEMENT LLC----10,400-100.00%-Mar 31, 2024
BANK OF AMERICA CORP /DE/----10,000-100.00%-Mar 31, 2024
POLAR ASSET MANAGEMENT PARTNERS INC.----9,900-100.00%-Mar 31, 2024
WELLS FARGO & COMPANY/MN----9,100-100.00%-Mar 31, 2024
BANK OF MONTREAL /CAN/----7,763-100.00%-Mar 31, 2024
WELLINGTON MANAGEMENT GROUP LLP----5,227-100.00%-Mar 31, 2024
CITIGROUP INC----5,000-100.00%-Mar 31, 2024
WOLVERINE TRADING, LLC----4,503-100.00%-Mar 31, 2024
HRT FINANCIAL LP----3,716-100.00%-Mar 31, 2024
CINCTIVE CAPITAL MANAGEMENT LP----2,350-100.00%-Mar 31, 2024
BREVAN HOWARD CAPITAL MANAGEMENT LP----2,293-100.00%-Mar 31, 2024
AXQ CAPITAL, LP----2,200-100.00%-Mar 31, 2024
Y-INTERCEPT (HONG KONG) LTD----1,551-100.00%-Mar 31, 2024
CAPTRUST FINANCIAL ADVISORS----1,474-100.00%-Mar 31, 2024
SIERRA SUMMIT ADVISORS LLC----1,434-100.00%-Mar 31, 2024
MBB PUBLIC MARKETS I LLC----1,400-100.00%-Mar 31, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)----1,247-100.00%-Mar 31, 2024
SCIENTECH RESEARCH LLC----1,102-100.00%-Mar 31, 2024
GLENMEDE TRUST CO NA----1,066-100.00%-Mar 31, 2024
MARATHON TRADING INVESTMENT MANAGEMENT LLC----1,000-100.00%-Mar 31, 2024
EDGESTREAM PARTNERS, L.P.----987-100.00%-Mar 31, 2024
CENTERBOOK PARTNERS LP----953-100.00%-Mar 31, 2024
NATIXIS----857-100.00%-Mar 31, 2024
HIGHTOWER ADVISORS, LLC----600-100.00%-Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC----500-100.00%-Mar 31, 2024
WIT, LLC----35-100.00%-Mar 31, 2024
RONALD BLUE TRUST, INC.----19-100.00%-Mar 31, 2024

Madrigal Pharmaceuticals's largest sold out institutional shareholder by shares sold is ARMISTICE CAPITAL, LLC, sold -0.28M shares, valued at -, as of undefined.

Madrigal Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Alger ETF Trust0.42%2,970--Dec 31, 2023
HARTFORD HLS SERIES FUND II INC0.23%56,641--Dec 31, 2023
Tema ETF Trust0.10%4,4032,945201.99%Feb 29, 2024
NEW ECONOMY FUND0.09%387,221--Feb 29, 2024
LORD ABBETT DEVELOPING GROWTH FUND, INC.0.05%50,627-3,038-5.66%Jan 31, 2024
AB DISCOVERY GROWTH FUND, INC.0.04%61,552-14-0.02%Jan 31, 2024
GROWTH FUND OF AMERICA0.04%923,524--Feb 29, 2024
EntrepreneurShares Series Trust0.03%8,1976,058283.22%Dec 31, 2023
DELAWARE GROUP EQUITY FUNDS IV0.03%28,500--Dec 29, 2023
ALGER FUNDS0.03%25,10313,886123.79%Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS0.02%10,230--Dec 31, 2023
VIRTUS ALTERNATIVE SOLUTIONS TRUST0.01%55--Jan 31, 2024
Nuveen NASDAQ 100 Dynamic Overwrite Fund0.01%1,618-730-31.09%Dec 31, 2023
TEKLA LIFE SCIENCES INVESTORS0.01%7,090--Dec 31, 2023
T. Rowe Price Quantitative Management Funds, Inc.0.01%39,0377001.83%Dec 31, 2023
T. Rowe Price Small-Cap Stock Fund, Inc.0.01%39,601--Dec 31, 2023
PRUDENTIAL SECTOR FUNDS, INC.0.01%21,451--Feb 29, 2024
TEKLA HEALTHCARE INVESTORS0.01%10,540--Dec 31, 2023
Humankind Benefit Corp0.01%20620.98%Dec 31, 2023
Voya VARIABLE PRODUCTS TRUST0.01%2,269--Dec 31, 2023
VALUE LINE CAPITAL APPRECIATION FUND INC0.01%13,00013,000-Dec 31, 2023
AMERICAN CENTURY MUTUAL FUNDS, INC.0.01%70,53011,60519.69%Jan 31, 2024
SMALLCAP WORLD FUND INC0.01%428,422--Dec 31, 2023
JANUS INVESTMENT FUND0.01%1,999,697366,09222.41%Dec 31, 2023
FIDELITY ADVISOR SERIES VII0.01%53,400-18,100-25.31%Jan 31, 2024
T. Rowe Price Diversified Mid-Cap Growth Fund, Inc.0.01%2,989--Dec 31, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%2,2551959.47%Dec 31, 2023
QUANTITATIVE MASTER SERIES LLC0.00%26,8533,76116.29%Dec 31, 2023
FIDELITY CAPITAL TRUST0.00%38,9007001.83%Jan 31, 2024
TOCQUEVILLE TRUST0.00%500--Jan 31, 2024
VANGUARD INDEX FUNDS0.00%1,632,991325,52224.90%Dec 31, 2023
ALLSPRING VARIABLE TRUST0.00%1,538--Dec 31, 2023
FIDELITY SELECT PORTFOLIOS0.00%139,408-27,100-16.28%Feb 29, 2024
PROFESSIONALLY MANAGED PORTFOLIOS0.00%12,039--Feb 29, 2024
VANGUARD EXPLORER FUND0.00%25,105--Jan 31, 2024
FIDELITY COMMONWEALTH TRUST0.00%6,490931.45%Feb 29, 2024
FIDELITY SECURITIES FUND0.00%160,400-18,300-10.24%Jan 31, 2024
ALPS ETF Trust0.00%19,964--Feb 29, 2024
Bernstein Fund Inc0.00%16,300--Dec 31, 2023
FIDELITY MT VERNON STREET TRUST0.00%42,903--Feb 29, 2024
Federated Hermes MDT Series0.00%3,298--Jan 31, 2024
JANUS ASPEN SERIES0.00%51,93314,56038.96%Dec 31, 2023
T. Rowe Price Equity Funds, Inc.0.00%20,548--Dec 31, 2023
TIAA SEPARATE ACCOUNT VA 10.00%275--Dec 31, 2023
JNL VARIABLE FUND LLC0.00%6,454--Mar 31, 2020
ROYCE MICRO-CAP TRUST, INC.0.00%490--Dec 31, 2023
HARTFORD SERIES FUND INC0.00%38,642--Dec 31, 2023
ETF Managers Trust0.00%6,518--Dec 31, 2023
MUTUAL OF AMERICA INSTITUTIONAL FUNDS INC0.00%4599927.50%Sep 30, 2020
FIRST TRUST EXCHANGE-TRADED FUND VI0.00%3,286--Dec 31, 2023
Fidelity Commonwealth Trust II0.00%4,832--Aug 31, 2023
FIDELITY CONCORD STREET TRUST0.00%148,9645,4833.82%Feb 29, 2024
RYDEX SERIES FUNDS0.00%2,7352379.49%Dec 31, 2023
Calvert Variable Products, Inc.0.00%1,53217913.23%Dec 31, 2023
FEDERATED HERMES INSURANCE SERIES0.00%2,597--Dec 31, 2023
ProFunds0.00%4,7952,25488.71%Jan 31, 2024
FINANCIAL INVESTORS TRUST0.00%38,63222,137134.20%Jan 31, 2024
Mutual of America Variable Insurance Portfolios, Inc.0.00%344-5-1.43%Sep 30, 2023
SCHWAB STRATEGIC TRUST0.00%82,3333,5764.54%Feb 29, 2024
AB VARIABLE PRODUCTS SERIES FUND, INC.0.00%1,691--Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%10,7267377.38%Dec 31, 2023
OLD WESTBURY FUNDS INC0.00%45,830-723-1.55%Jan 31, 2024
MML SERIES INVESTMENT FUND0.00%3,302--Dec 31, 2023
RYDEX VARIABLE TRUST0.00%380308.57%Dec 31, 2023
MUTUAL OF AMERICA INVESTMENT CORP0.00%12,803-228-1.75%Dec 31, 2023
KINETICS PORTFOLIOS TRUST0.00%514--Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.00%5,028--Feb 29, 2024
NORTHWESTERN MUTUAL SERIES FUND INC0.00%35,062--Dec 31, 2023
Direxion Shares ETF Trust0.00%41,3735,70515.99%Jan 31, 2024
ETFis Series Trust I0.00%352-36-9.28%Jan 31, 2024
HARTFORD MUTUAL FUNDS II INC0.00%36,455--Jan 31, 2024
ARTISAN PARTNERS FUNDS INC0.00%186,80444,84031.59%Dec 31, 2023
Forethought Variable Insurance Trust0.00%852--Dec 29, 2023
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%758--Dec 31, 2023
INVESCO EXCHANGE-TRADED FUND TRUST0.00%15,777--Jan 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%5,8484077.48%Dec 31, 2023
Advisors' Inner Circle Fund III0.00%2,55664934.03%Jan 31, 2024
PENN SERIES FUNDS INC0.00%4,93297724.70%Dec 29, 2023
Principal Exchange-Traded Funds0.00%2,013-165-7.58%Mar 31, 2024
VANGUARD WORLD FUND0.00%39,9383,2958.99%Feb 29, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%71481.13%Dec 31, 2023
OHIO NATIONAL FUND INC0.00%3,127-42-1.33%Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND II0.00%1,970-1,985-50.19%Dec 31, 2023
AMG Funds I0.00%213--Jan 31, 2024
SunAmerica Specialty Series0.00%72--Apr 30, 2021
LORD ABBETT BOND DEBENTURE FUND INC0.00%35,764--Dec 31, 2023
PFM Multi-Manager Series Trust0.00%100--Dec 31, 2023
NEW COVENANT FUNDS0.00%531--Dec 31, 2023
FIDELITY COVINGTON TRUST0.00%1,70144635.54%Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%105,678--Jan 31, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.00%4,841--Dec 31, 2023
TIAA-CREF LIFE FUNDS0.00%221--Dec 31, 2023
HC CAPITAL TRUST0.00%2,208--Dec 31, 2023
TIFF INVESTMENT PROGRAM0.00%3,100--Dec 31, 2023
LORD ABBETT SERIES FUND INC0.00%1,443--Dec 31, 2023
Voya INVESTORS TRUST0.00%3,205-148-4.41%Dec 31, 2023
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%5,2591,00023.48%Dec 31, 2023
EQ ADVISORS TRUST0.00%61,7092,1293.57%Dec 31, 2023
SUNAMERICA SERIES TRUST0.00%16,7491270.76%Jan 31, 2024
VIRTUS ASSET TRUST0.00%1,213--Dec 29, 2023

Madrigal Pharmaceuticals's largest mutual fund holder by % of total assets is "Alger ETF Trust", owning 2.97K shares, compromising 0.42% of its total assets.

Madrigal Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 24155-38.74%
31 Dec, 2325311.45%
30 Sep, 23227-2.58%
30 Jun, 23233-4.12%
31 Mar, 2324313.55%
31 Dec, 2221444.59%
30 Sep, 22148-0.67%
30 Jun, 221492.76%
31 Mar, 22145-3.33%
31 Dec, 211507.14%
30 Sep, 21140-8.50%
30 Jun, 211537.75%
31 Mar, 211420.71%
31 Dec, 201411.44%
30 Sep, 201392.96%
30 Jun, 2013521.62%
31 Mar, 20111-13.95%
31 Dec, 191298.40%
30 Sep, 19119-9.85%
30 Jun, 19132-12.58%
31 Mar, 191512.72%
31 Dec, 18147-12.50%
30 Sep, 181689.09%
30 Jun, 1815455.56%
31 Mar, 189911.24%
31 Dec, 178978.00%
30 Sep, 175028.21%
30 Jun, 173950.00%
31 Mar, 17264.00%
31 Dec, 1625-10.71%
30 Sep, 1628-

As of 31 Mar 24, 155 institutions are holding Madrigal Pharmaceuticals's shares, representing a decrease of -38.74% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 246,500,609-66.46%
31 Dec, 2319,381,55014.28%
30 Sep, 2316,959,68215.40%
30 Jun, 2314,696,3767.97%
31 Mar, 2313,611,0402.29%
31 Dec, 2213,306,77713.54%
30 Sep, 2211,719,650-2.38%
30 Jun, 2212,005,530-1.83%
31 Mar, 2212,229,1692.82%
31 Dec, 2111,893,6078.75%
30 Sep, 2110,936,360-2.39%
30 Jun, 2111,204,474-8.06%
31 Mar, 2112,186,285-0.43%
31 Dec, 2012,239,3575.65%
30 Sep, 2011,585,1582.99%
30 Jun, 2011,249,0072.20%
31 Mar, 2011,006,4715.66%
31 Dec, 1910,416,4148.07%
30 Sep, 199,638,7030.85%
30 Jun, 199,556,9941.61%
31 Mar, 199,405,64510.96%
31 Dec, 188,476,533-1.79%
30 Sep, 188,630,8586.26%
30 Jun, 188,122,39028.36%
31 Mar, 186,327,77623.53%
31 Dec, 175,122,30891.60%
30 Sep, 172,673,43030.58%
30 Jun, 172,047,31934.89%
31 Mar, 171,517,80212.79%
31 Dec, 161,345,66033.60%
30 Sep, 161,007,212-

Madrigal Pharmaceuticals (MDGL) has 6.50M shares outstanding as of 31 Mar 24, down -66.46% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2432.90%0.30%
31 Dec, 23104.90%1.22%
30 Sep, 2392.62%1.42%
30 Jun, 2380.80%1.44%
31 Mar, 2374.84%1.24%
31 Dec, 2277.65%1.65%
30 Sep, 2268.52%1.39%
30 Jun, 2270.19%1.37%
31 Mar, 2271.50%1.47%
31 Dec, 2169.66%1.61%
30 Sep, 2165.72%1.44%
30 Jun, 2167.61%1.14%
31 Mar, 2176.93%1.23%
31 Dec, 2079.09%1.41%
30 Sep, 2074.99%1.41%
30 Jun, 2072.89%1.43%
31 Mar, 2071.34%1.56%
31 Dec, 1967.66%1.73%
30 Sep, 1962.53%1.62%
30 Jun, 1962.18%1.66%
31 Mar, 1961.22%2.01%
31 Dec, 1855.23%1.74%
30 Sep, 1856.38%1.77%
30 Jun, 1856.47%2.81%
31 Mar, 1844.79%2.56%
31 Dec, 1741.83%8.97%
30 Sep, 1721.60%7.47%
30 Jun, 1717.01%10.55%
31 Mar, 1712.70%9.29%
31 Dec, 1611.69%12.61%
30 Sep, 169.63%-

As of 31 Mar 24, Madrigal Pharmaceuticals is held by 32.90% institutional shareholders, representing a 0.30% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 2487-41.61%
31 Dec, 2314920.16%
30 Sep, 23124-3.88%
30 Jun, 23129-9.15%
31 Mar, 23142-0.70%
31 Dec, 2214395.89%
30 Sep, 22738.96%
30 Jun, 22671.52%
31 Mar, 2266-10.81%
31 Dec, 217429.82%
30 Sep, 2157-32.94%
30 Jun, 218525.00%
31 Mar, 21683.03%
31 Dec, 206624.53%
30 Sep, 2053-27.40%
30 Jun, 207321.67%
31 Mar, 2060-11.76%
31 Dec, 19684.62%
30 Sep, 1965-9.72%
30 Jun, 1972-4.00%
31 Mar, 19752.74%
31 Dec, 1873-27.00%
30 Sep, 18100-9.09%
30 Jun, 1811064.18%
31 Mar, 1867-6.94%
31 Dec, 1772132.26%
30 Sep, 1731-
30 Jun, 173193.75%
31 Mar, 171645.45%
31 Dec, 1611-59.26%
30 Sep, 1627-

87 institutional shareholders have increased their position in MDGL stock as of 31 Mar 24 compared to 149 in the previous quarter (a -41.61% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 2439-35.00%
31 Dec, 23607.14%
30 Sep, 2356-
30 Jun, 2356-11.11%
31 Mar, 236361.54%
31 Dec, 223914.71%
30 Sep, 2234-17.07%
30 Jun, 2241-2.38%
31 Mar, 224213.51%
31 Dec, 2137-5.13%
30 Sep, 21392.63%
30 Jun, 2138-5.00%
31 Mar, 2140-
31 Dec, 2040-13.04%
30 Sep, 204635.29%
30 Jun, 203421.43%
31 Mar, 2028-20.00%
31 Dec, 193540.00%
30 Sep, 1925-3.85%
30 Jun, 1926-18.75%
31 Mar, 1932-31.91%
31 Dec, 184711.90%
30 Sep, 184223.53%
30 Jun, 183441.67%
31 Mar, 1824140.00%
31 Dec, 171025.00%
30 Sep, 178166.67%
30 Jun, 173-
31 Mar, 173-25.00%
31 Dec, 164-
30 Sep, 16--

39 institutional shareholders have reduced their position in MDGL stock as of 31 Mar 24 compared to 60 in the previous quarter (a -35.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 24155-38.74%6,500,609-66.46%32.90%0.30%87-41.61%39-35.00%
31 Dec, 2325311.45%19,381,55014.28%104.90%1.22%14920.16%607.14%
30 Sep, 23227-2.58%16,959,68215.40%92.62%1.42%124-3.88%56-
30 Jun, 23233-4.12%14,696,3767.97%80.80%1.44%129-9.15%56-11.11%
31 Mar, 2324313.55%13,611,0402.29%74.84%1.24%142-0.70%6361.54%
31 Dec, 2221444.59%13,306,77713.54%77.65%1.65%14395.89%3914.71%
30 Sep, 22148-0.67%11,719,650-2.38%68.52%1.39%738.96%34-17.07%
30 Jun, 221492.76%12,005,530-1.83%70.19%1.37%671.52%41-2.38%
31 Mar, 22145-3.33%12,229,1692.82%71.50%1.47%66-10.81%4213.51%
31 Dec, 211507.14%11,893,6078.75%69.66%1.61%7429.82%37-5.13%
30 Sep, 21140-8.50%10,936,360-2.39%65.72%1.44%57-32.94%392.63%
30 Jun, 211537.75%11,204,474-8.06%67.61%1.14%8525.00%38-5.00%
31 Mar, 211420.71%12,186,285-0.43%76.93%1.23%683.03%40-
31 Dec, 201411.44%12,239,3575.65%79.09%1.41%6624.53%40-13.04%
30 Sep, 201392.96%11,585,1582.99%74.99%1.41%53-27.40%4635.29%
30 Jun, 2013521.62%11,249,0072.20%72.89%1.43%7321.67%3421.43%
31 Mar, 20111-13.95%11,006,4715.66%71.34%1.56%60-11.76%28-20.00%
31 Dec, 191298.40%10,416,4148.07%67.66%1.73%684.62%3540.00%
30 Sep, 19119-9.85%9,638,7030.85%62.53%1.62%65-9.72%25-3.85%
30 Jun, 19132-12.58%9,556,9941.61%62.18%1.66%72-4.00%26-18.75%
31 Mar, 191512.72%9,405,64510.96%61.22%2.01%752.74%32-31.91%
31 Dec, 18147-12.50%8,476,533-1.79%55.23%1.74%73-27.00%4711.90%
30 Sep, 181689.09%8,630,8586.26%56.38%1.77%100-9.09%4223.53%
30 Jun, 1815455.56%8,122,39028.36%56.47%2.81%11064.18%3441.67%
31 Mar, 189911.24%6,327,77623.53%44.79%2.56%67-6.94%24140.00%
31 Dec, 178978.00%5,122,30891.60%41.83%8.97%72132.26%1025.00%
30 Sep, 175028.21%2,673,43030.58%21.60%7.47%31-8166.67%
30 Jun, 173950.00%2,047,31934.89%17.01%10.55%3193.75%3-
31 Mar, 17264.00%1,517,80212.79%12.70%9.29%1645.45%3-25.00%
31 Dec, 1625-10.71%1,345,66033.60%11.69%12.61%11-59.26%4-
30 Sep, 1628-1,007,212-9.63%-27---

Madrigal Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 16, 2024CRAVES FRED Bdirector-S-SaleSell8,827$210.99$1.86M427,024
May 16, 2024CRAVES FRED Bdirector-S-SaleSell5,009$211.84$1.06M422,015
May 16, 2024CRAVES FRED Bdirector-S-SaleSell1,363$212.85$290.12K420,652
May 16, 2024CRAVES FRED Bdirector-S-SaleSell2,190$213.85$468.34K418,462
May 16, 2024CRAVES FRED Bdirector-S-SaleSell1,804$214.68$387.29K416,658
May 16, 2024CRAVES FRED Bdirector-S-SaleSell375$216.08$81.03K416,283
May 16, 2024CRAVES FRED Bdirector-S-SaleSell721$216.98$156.45K415,562
May 16, 2024CRAVES FRED Bdirector-S-SaleSell1,100$217.86$239.64K414,462
May 16, 2024CRAVES FRED Bdirector-S-SaleSell1,000$218.99$218.99K413,462
May 16, 2024CRAVES FRED Bdirector-S-SaleSell100$219.90$21.99K413,362
Apr 10, 2024Taub Rebeccadirector, officer Pres., R&D, and CMOS-SaleSell224$243.25$54.49K461,451
Apr 10, 2024Taub Rebeccadirector, officer Pres., R&D, and CMOS-SaleSell945$244.79$231.32K460,506
Apr 10, 2024Taub Rebeccadirector, officer Pres., R&D, and CMOS-SaleSell300$245.69$73.71K460,206
Apr 10, 2024Taub Rebeccadirector, officer Pres., R&D, and CMOS-SaleSell600$246.98$148.19K459,606
Apr 10, 2024Taub Rebeccadirector, officer Pres., R&D, and CMOS-SaleSell407$247.76$100.84K459,199

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 16, 2024CRAVES FRED Bdirector-S-SaleSell8,827$210.99$1.86M427,024
May 16, 2024CRAVES FRED Bdirector-S-SaleSell5,009$211.84$1.06M422,015
May 16, 2024CRAVES FRED Bdirector-S-SaleSell1,363$212.85$290.12K420,652
May 16, 2024CRAVES FRED Bdirector-S-SaleSell2,190$213.85$468.34K418,462
May 16, 2024CRAVES FRED Bdirector-S-SaleSell1,804$214.68$387.29K416,658
May 16, 2024CRAVES FRED Bdirector-S-SaleSell375$216.08$81.03K416,283
May 16, 2024CRAVES FRED Bdirector-S-SaleSell721$216.98$156.45K415,562
May 16, 2024CRAVES FRED Bdirector-S-SaleSell1,100$217.86$239.64K414,462
May 16, 2024CRAVES FRED Bdirector-S-SaleSell1,000$218.99$218.99K413,462
May 16, 2024CRAVES FRED Bdirector-S-SaleSell100$219.90$21.99K413,362
May 16, 2024CRAVES FRED Bdirector-M-ExemptSell10,000$100.45$1.00M-
May 16, 2024CRAVES FRED Bdirector-M-ExemptSell12,489$105.08$1.31M-
Apr 10, 2024Taub Rebeccadirector, officer Pres., R&D, and CMOS-SaleSell224$243.25$54.49K461,451
Apr 10, 2024Taub Rebeccadirector, officer Pres., R&D, and CMOS-SaleSell945$244.79$231.32K460,506
Apr 10, 2024Taub Rebeccadirector, officer Pres., R&D, and CMOS-SaleSell300$245.69$73.71K460,206
Apr 10, 2024Taub Rebeccadirector, officer Pres., R&D, and CMOS-SaleSell600$246.98$148.19K459,606
Apr 10, 2024Taub Rebeccadirector, officer Pres., R&D, and CMOS-SaleSell407$247.76$100.84K459,199

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 16, 2024CRAVES FRED Bdirector-M-ExemptBuy12,489$105.08$1.31M435,851
May 16, 2024CRAVES FRED Bdirector-S-SaleSell8,827$210.99$1.86M427,024
May 16, 2024CRAVES FRED Bdirector-M-ExemptBuy10,000$100.45$1.00M423,362
May 16, 2024CRAVES FRED Bdirector-S-SaleSell5,009$211.84$1.06M422,015
May 16, 2024CRAVES FRED Bdirector-S-SaleSell1,363$212.85$290.12K420,652
May 16, 2024CRAVES FRED Bdirector-S-SaleSell2,190$213.85$468.34K418,462
May 16, 2024CRAVES FRED Bdirector-S-SaleSell1,804$214.68$387.29K416,658
May 16, 2024CRAVES FRED Bdirector-S-SaleSell375$216.08$81.03K416,283
May 16, 2024CRAVES FRED Bdirector-S-SaleSell721$216.98$156.45K415,562
May 16, 2024CRAVES FRED Bdirector-S-SaleSell1,100$217.86$239.64K414,462
May 16, 2024CRAVES FRED Bdirector-S-SaleSell1,000$218.99$218.99K413,462
May 16, 2024CRAVES FRED Bdirector-S-SaleSell100$219.90$21.99K413,362
May 16, 2024CRAVES FRED Bdirector-M-ExemptSell10,000$100.45$1.00M-
May 16, 2024CRAVES FRED Bdirector-M-ExemptSell12,489$105.08$1.31M-
Apr 10, 2024Taub Rebeccadirector, officer Pres., R&D, and CMOM-ExemptBuy2,676$9.45$25.29K461,675
Apr 10, 2024Taub Rebeccadirector, officer Pres., R&D, and CMOS-SaleSell224$243.25$54.49K461,451
Apr 10, 2024Taub Rebeccadirector, officer Pres., R&D, and CMOS-SaleSell945$244.79$231.32K460,506
Apr 10, 2024Taub Rebeccadirector, officer Pres., R&D, and CMOS-SaleSell300$245.69$73.71K460,206
Apr 10, 2024Taub Rebeccadirector, officer Pres., R&D, and CMOS-SaleSell600$246.98$148.19K459,606
Apr 10, 2024Taub Rebeccadirector, officer Pres., R&D, and CMOS-SaleSell407$247.76$100.84K459,199

The last insider sell of Madrigal Pharmaceuticals's stock was made by CRAVES FRED B on May 16 2024, selling 8,827 shares at $210.99 per share (valued at $1.86M).

Madrigal Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20241710815.74%
Q1 2024207285.71%
Q4 202315027555.56%
Q3 20232--
Q2 20236--
Q1 2023103231.25%
Q4 20221342.94%
Q3 20222--
Q2 202210--
Q1 202261600.00%
Q4 20211616.67%
Q3 20211--
Q2 20217--
Q1 20215--
Q4 2020-1-
Q3 20201128.33%
Q2 20206785.71%
Q1 202041400.00%
Q4 2019-4-
Q3 20191--

17 total buy trades, and 108 total sell trades (buy/sell ratio of 0.16%) were made by Madrigal Pharmaceuticals's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-91-
Q1 20242--
Q4 202314016875.00%
Q3 2023---
Q2 2023---
Q1 2023-26-
Q4 2022-32-
Q3 2022---
Q2 2022---
Q1 2022---
Q4 2021---
Q3 2021---
Q2 2021---
Q1 2021---
Q4 2020---
Q3 2020-6-
Q2 2020---
Q1 2020---
Q4 2019-4-
Q3 2019---

As of Q2 2024, Insider owners conducted 0 open market buy trades and 91 open market sell trades of Madrigal Pharmaceuticals's stocks.

Madrigal Pharmaceuticals Peer Ownership


TickerCompany
TERNTerns Pharmaceuticals, Inc.
ABOSAcumen Pharmaceuticals, Inc.
PTCTPTC Therapeutics, Inc.
TGTXTG Therapeutics, Inc.
PLRXPliant Therapeutics, Inc.
MREOMereo BioPharma Group plc
ETNB89bio, Inc.
VKTXViking Therapeutics, Inc.
STOKStoke Therapeutics, Inc.
IOVAIovance Biotherapeutics, Inc.
XFORX4 Pharmaceuticals, Inc.
INZYInozyme Pharma, Inc.
DAWNDay One Biopharmaceuticals, Inc.
SRPTSarepta Therapeutics, Inc.
ACLXArcellx, Inc.
HEPAHepion Pharmaceuticals, Inc.
KRYSKrystal Biotech, Inc.

MDGL Ownership FAQ


Madrigal Pharmaceuticals is owned by institutional shareholders (32.90%), insiders (15.35%), and public (51.75%). The largest institutional shareholder of Madrigal Pharmaceuticals is JANUS HENDERSON GROUP PLC (13.16% of total shares) and the top mutual fund owner is Alger ETF Trust (0.42% of total shares).

Madrigal Pharmaceuticals's major institutional shareholders are JANUS HENDERSON GROUP PLC, BAKER BROS. ADVISORS LP, AVORO CAPITAL ADVISORS LLC, PAULSON & CO. INC., and VANGUARD GROUP INC. The top five shareholders own together 50.40% of the company's share outstanding.

As of Mar 2024, there are 155 institutional shareholders of Madrigal Pharmaceuticals.

JANUS HENDERSON GROUP PLC owns 2.6M shares of Madrigal Pharmaceuticals, representing 13.16% of the company's total shares outstanding, valued at $694.53M (as of Mar 2024).

As of Mar 2024, BAKER BROS. ADVISORS LP holds 1.97M shares of Madrigal Pharmaceuticals (MDGL), compromising 9.97% of the company, valued at $526.01M.

AVORO CAPITAL ADVISORS LLC is the third largest holder of Madrigal Pharmaceuticals. The company owns 1.94M of the company's shares outstanding (worth $519.24M).